文献速递骨质疏松与钙磷/甲状旁腺

低磷性佝偻病的诊疗路径

Approach to Hypophosphatemic Rickets.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

本文综述低磷性佝偻病的评估与治疗路径,该病多在婴幼儿期表现为骨骼畸形和生长板异常,最常见的病因是遗传性(如X连锁低磷血症),可导致终生低磷血症和骨软化。文章强调应检测血清磷,结合病史、体检、实验室检查、基因分析和影像学明确病因,治疗依病因选择活性维生素D联合磷酸盐或抗FGF23抗体(布罗索尤单抗)。

要点

  • 低磷性佝偻病多在婴幼儿期表现为骨骼畸形和生长板异常,最常见病因为遗传性如X连锁低磷血症。
  • 对疑诊佝偻病或骨软化的儿童或成人应检测血清磷。
  • 治疗依病因而定,常用活性维生素D联合磷酸盐,X连锁低磷血症可用抗FGF23抗体布罗索尤单抗。

核心结论

  • 低磷性佝偻病的评估需结合病史、体检、实验室检查、基因分析和影像学以明确病因并监测严重程度和治疗过程。

研究设计与样本

  • 本文为综述,探讨低磷性佝偻病的评估方法和治疗选择。

主要发现

  • 低磷性佝偻病通常在婴儿期或幼儿早期出现骨骼畸形和生长板异常。
  • 最常见病因是遗传性(如X连锁低磷血症),通常导致终生低磷血症和骨软化。
  • 成纤维细胞生长因子23(FGF23)是骨细胞产生的激素,可下调肾脏磷酸盐重吸收和1,25-二羟维生素D(1,25(OH)2D)生成。
  • 对任何有提示佝偻病或骨软化的肌肉骨骼症状的儿童或成人应检测血清磷。
  • 临床评估包括详细病史、体格检查、实验室检查、基因分析(尤其在没有明确家族史时)和影像学。

临床怎么用

  • 治疗取决于病因,常包括活性维生素D联合磷酸盐,或对X连锁低磷血症使用抗FGF23抗体(布罗索尤单抗)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hypophosphatemic rickets typically presents in infancy or early childhood with skeletal deformities and growth plate abnormalities. The most common causes are genetic (such as X-linked hypophosphatemia), and these typically will result in lifelong hypophosphatemia and osteomalacia. Knowledge of phosphate metabolism, including the effects of fibroblast growth factor 23 (FGF23) (an osteocyte produced hormone that downregulates renal phosphate reabsorption and 1,25-dihydroxyvitamin-D (1,25(OH)2D) production), is critical to determining the underlying genetic or acquired causes of hypophosphatemia and to facilitate appropriate treatment. Serum phosphorus should be measured in any child or adult with musculoskeletal complaints suggesting rickets or osteomalacia. Clinical evaluation incudes thorough history, physical examination, laboratory investigations, genetic analysis (especially in the absence of a guiding family history), and imaging to establish etiology and to monitor severity and treatment course. The treatment depends on the underlying cause, but often includes active forms of vitamin D combined with phosphate salts, or anti-FGF23 antibody treatment (burosumab) for X-linked hypophosphatemia. The purpose of this article is to explore the approach to evaluating hypophosphatemic rickets and its treatment options.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ackah SA, Imel EA. Approach to Hypophosphatemic Rickets. J Clin Endocrinol Metab. 2022. PMID: 35981346. doi:10.1210/clinem/dgac488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。